ClinicalTrials.gg
RecruitingNCT06156306Updated Jul 10, 2025

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

An interventional study of CBT-I and CBT-I combined ACT in Insomnia, Anxiety and Youth, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 15 Years to 24 Years. Per ClinicalTrials.gov, last updated 2025-07-10.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Dec 2023; still recruiting 2 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
15 Years to 24 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong — 14 open to participants now, 14 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Chinese University of Hong Kong.

Planned enrollment
19th of 25
50 · median 80
Started
2023
with 3 others
No phase
24 of 25
13 open now
Primary completion
2025-12
later than 1 of 13 live
Registered
14th of 25
by date

Among the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong, this one is the 19th largest by planned enrollment, is one of 4 that started in 2023, is one of 24 with no phase, reaches primary completion later than 1 of the 13 other live ones, and was the 14th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

14 of the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 15 Years to 24 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

Insomnia in adolescents and youth is a long-standing public health concern due to its high prevalence and association with various physical and mental health problems. Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. CBT for insomnia (CBT-I) has been shown to be effective in improving sleep complaints and short-term improvement in mood while previous systematic reviews of interventional studies have demonstrated the effectiveness of acceptance and commitment therapy (ACT) interventions in treating insomnia, both as a primary condition and with other physical and/or mental health comorbidities. This study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth.

Read the detailed description

Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. Moreover, approximately three-quarters of anxious youth also report sleep-related problems. Literature reviews have investigated the relationship and the shared underlying mechanisms between sleep and anxiety. Anxiety sensitivity and pre-sleep arousal have been found to play a critical role in difficulty initiating sleep, which is the most common insomnia symptoms in adolescent population, partially due their natural delay of circadian rhythm. The findings suggest shared neurological and cognitive features that may account for dysregulation of both sleep and affect. Management targeting both sleep and anxiety is recommended due to potentially higher treatment efficacy and cost-effectiveness.

Accumulating evidence supports the effectiveness of cognitive-behavioural therapy for insomnia (CBT-I) and acceptance and commitment therapy (ACT) for addressing sleep and mood problems in adolescents. However, Only a few studies have directly compared the effectiveness of CBT-I and ACT. Past studies have shown that both CBT-I and ACT were effective in treating insomnia in adults.

This current study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth. The primary hypothesis is that subjects in CBT-I combined ACT will have fewer anxiety symptoms as compared to CBT-I at post-intervention and 3-month follow-up.

03

Conditions studied

  • Insomnia
  • Anxiety
  • Youth

Keywords

  • Insomnia
  • Anxiety
  • Youth
04

Who can participate

Ages eligible
15 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Youth who meet the following criteria would be eligible for taking part in this trial:

i. Chinese youth aged 15-24 years old, ii. Presence of insomnia problems as defined by insomnia severity index (ISI) using cut-off of 9, which has been locally validated cut off for detecting clinical insomnia), iii. Presence of anxiety features as defined by General Anxiety Disorder-7 (GAD-7) using cut-off of 10 for detecting clinical anxiety, iv. Ability to listen, speak, and read Chinese and Cantonese, and v. Written of participation into the study is given by youth and his/her parent's if under 18 years old; In addition, individual assent will also be obtained for subjects under age 18 years old vi. Possession of smartphone

Exclusion criteria

Exclusion Criteria:

A youth would be excluded from the study if meeting one or more of the following criteria:

i. A clinical diagnosis of psychosis, schizophrenia, bipolar disorders, or intellectual disability ii. Having a diagnosed sleep disorder (e.g. delayed sleep phase and narcolepsy) that may potentially contribute to the disruption of sleep quantity and quality as determined by validated Diagnostic Interview for Sleep Patterns and Disorders (DISP) iii. Having a suicidality (presence of suicidal ideation with a plan or an attempt) as assessed by The Structured Clinical Interview (SCID) iv. Currently receiving psychological treatment and/or pharmacological treatment for insomnia or anxiety disorder.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    CBT-I

    A total of 6 sessions of face-to-face group CBT-I therapy will be provided. Each session will last 90-120 mins, with each group 8-10 subjects.

    Behavioral: CBT-I

  • Experimental
    CBT-I combined ACT

    A total of 6 sessions of face-to-face group CBT-I+ACT therapy will be provided. Each session will last 90-120 mins, with each group 8-10 subjects.

    Behavioral: CBT-I combined ACT

Interventions

  • BehavioralCBT-I

    The CBT-I intervention will cover sleep education, stimulus control, sleep restriction, cognitive therapy and relaxation training.

  • BehavioralCBT-I combined ACT

    In addition to the standard CBT-I components, mindfulness, thought diary, and other ACT components will be taught in the group.

06

What researchers measure

Primary outcomes

  1. Severity of anxiety symptoms and severity

    General Anxiety Disorder-7 (GAD-7) will be used to assess anxiety symptoms and severity.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  2. Severity of anxiety symptoms

    Hospital Anxiety and Depression Scale (HADS) will be used to assess anxiety symptoms.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  3. Clinician-rated severity of anxiety symptoms

    Hamilton Anxiety Rating Scale (HAM-A) will be used to assess anxiety symptoms.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

Secondary outcomes

  1. Severity of insomnia symptoms

    Insomnia Severity Index (ISI) will be used to measure the severity of insomnia symptoms.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  2. Sleep-wake pattern

    Youths will be asked to keep a sleep diary to chart their daily sleep-wake pattern including sleep duration, wakeup time, bedtime and sleep latency

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  3. Daytime sleepiness

    Pediatric Daytime Sleepiness Scale (PDSS) will be used to assess adolescents' daytime sleepiness.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  4. Anxiety trait

    The State-Trait Anxiety Inventory (STAI) will be used to measure anxiety trait

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  5. Severity of depressive symptoms

    Patient Health Questionnaire 9-item (PHQ-9) will be used to measure the severity of depressive symptoms.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  6. Faulty sleep-related beliefs and cognitions

    Dysfunctional Beliefs and Attitudes about Sleep Scale-16-item (DBAS-16) will be used to measure faulty sleep-related beliefs and cognitions, which are cognitive aspects typically involved in the maintenance of insomnia.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  7. Frequency of an individual practice sleep hygiene

    Sleep Hygiene Practice Scale (SHPS) will be used to measure the frequency of an individual practice sleep hygiene.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  8. Psychological flexibility and experiential avoidance

    Acceptance and Action Questionnaire-II (AAQ-II) is related to the underlying ACT theory to measure psychological flexibility and experiential avoidance.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  9. Individual's state of arousal

    Pre-Sleep Arousal Scale (PSAS) will be used to measure individual's state of arousal as one falls asleep.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  10. Tendency to ruminate

    The Ruminative Responses Scale - short version (RRS-10) is a 10-item scale on a 4-likert scale. It measures the tendency to ruminate.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  11. Major life events and hassles

    The Adolescent Stress Index (ASI), which was developed using a Hong Kong student sample, will be used to measure major life events and hassles

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  12. Global cognitive appraisal of one's life satisfaction

    The Satisfaction With Life Scale (SWLS): SWLS is a 5-item scale on a 7-Likert scale. It measures the global cognitive appraisal of one's life satisfaction.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

  13. Subjective well-being in the previous week

    The International Positive and Negative Affect Schedule Short Form (IPANAS-SF) will be used to capture the subjective well-being in the previous week. It has 9 items on a 5-Likert scale with previous study demonstrating satisfactory internal consistency reliability and reasonable nomological validity in Chinese youth.

    Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2023 (actual). Primary completion is estimated for Dec 2025, 24 months after the start.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 24 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2023
First posted
Dec 5, 2023
StartActual
Dec 15, 2023
Primary completionEst.
Dec 15, 2025
CompletionEst.
Dec 31, 2025
Last update
Jul 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06156306
Responsible party
CHAN NGAN YIN (Assistant Professor, Department of Psychiatry, Chinese University of Hong Kong) — Principal investigator
First posted
Dec 5, 2023
Start date
Dec 15, 2023
Primary completion
Dec 15, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jul 10, 2025

Study contacts

Rachel Ngan Yin Chan, PhD
Contact
rachel.chan@cuhk.edu.hk
39710550
Julia Wai Han Sun, M.S.Sc
Contact
julia.sun@cuhk.edu.hk
39710550
Rachel Ngan Yin Chan, PhD
principal investigator · Department of Psychiatry, the Chinese University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion